您的位置: 首页 > 2023年6月 第54卷 第6期 > 文字全文
2023年7月 第38卷 第7期11
目录

影响不全流产期待治疗效果的相关因素分析

Analysis of factors associated with the effect of expectant treatment of incomplete abortion

来源期刊: 广州医药 | 34-38 发布时间:2023-07-27 收稿时间:2025/11/13 18:33:23 阅读量:25
作者:
关键词:
不全流产宫腔残留危险因素前瞻研究
incomplete abortionuterine residualsrisk factorsprospective study
DOI:
10.3969/j.issn.1000-8535.2023.06.006
收稿时间:
2022-09-07 
修订日期:
 
接收日期:
 
引用总数:
1  
目的 探讨影响宫腔修复的因素,为不全流产妇女选择期待治疗提供理论依据。方法 2021年1月—12月在香港大学深圳医院招募早孕药流不全的患者534例,记录其人口学特征以及从排胎到流产后3周到月经复潮后的相关情况,通过多因素Logistic回归分析影响不全流产者宫腔修复的因素。结果 534例药流不全患者中,月经复潮后宫腔残留240例,残留率为44.9%;多因素Logistic回归分析显示,BMI(OR=0.888,95%CI:0.808~0.975)、子宫位置(OR=1.836,95%CI:1.139~2.958)、人工流产次数(OR=2.258,95%CI:1.078~4.728)、阴道流血时长(OR=0.344,95%CI:0.141~0.837)、残留物最大径线(OR=1.061,95%CI:1.031~1.092)、残留物血流信号2级/3级(OR=3.636,95%CI:1.790~7.394;OR=4.001,95%CI:1.561~10.256)是宫腔残留的影响因素。结论 宫腔残留的高危因素有子宫后位、残留物最大径线、1次以上的人工流产、2级及以上的残留物血流信号,且血流信号等级影响最大。BMI和阴道流血时长>3周是宫腔残留的保护因素。
Objective To investigate the factors affecting uterine cavity repair and to provide a theoretical basis for the choice of expectant treatment for women with incomplete abortion.Methods From January to December 2021,534 patients with incomplete abortions were recruited at University of Hong Kong-Shenzhen Hospital,and their demographic characteristics and correlations from expulsion of the gestational sac to 3 weeks after medication abortion and after menstrual resumption were recorded,and the factors affecting uterine cavity repair in incomplete abortions were analyzed by multifactorial logistic regression.Results In 534 women,there were 240 cases of uterine cavity remnants after menstrual return,with a remnant rate of 44.9%;the results of multifactorial logistic regression analysis showed that BMI(OR=0.888,95% CI:0.808-0.975),uterine position(OR=1.836,95% CI:1.139-2.958),number of abortions(OR=2.258,95% CI:1.078-4.728),length of vaginal bleeding(OR=0.344,95% CI:0.141-0.837),maximum diameter of residuals(OR=1.061,95% CI:1.031-1.092),and residual blood flow signal grade 2/3(OR=3.636,95% CI:1.790-7.394;OR=4.001,95%CI:1.561-10.256)were influential factors for uterine residuals.Conclusions High-risk factors for uterine residuals are posterior uterus,the maximum diameter of residuals,more than one abortion,grade 2 or higher residual blood flow signal,and the grade of blood flow signal had the greatest effect.BMI and duration of vaginal bleeding >3 weeks are protective factors for uterine residuals.
1、 刘红荣. 经阴道彩色多普勒超声对早孕药物流产监测的临床价值[D].青岛:青岛大学,2011. 刘红荣. 经阴道彩色多普勒超声对早孕药物流产监测的临床价值[D].青岛:青岛大学,2011.
2、 程兰. 米非司酮和前列腺素联用终止早孕62例的超声观察与评估[J].广东医学,2000,(6):512-513. 程兰. 米非司酮和前列腺素联用终止早孕62例的超声观察与评估[J].广东医学,2000,(6):512-513.
3、 李萍. 米非司酮联合米索前列醇实施药物流产效果影响因素分析[J].临床合理用药杂志,2022,15(10):109-111. 李萍. 米非司酮联合米索前列醇实施药物流产效果影响因素分析[J].临床合理用药杂志,2022,15(10):109-111.
4、 左燕,杨世民,荣晅,等.某三甲医院药物流产不全的影响因素分析及预防措施[J].西北药学杂志,2016,31(6):637-639. 左燕,杨世民,荣晅,等.某三甲医院药物流产不全的影响因素分析及预防措施[J].西北药学杂志,2016,31(6):637-639.
5、 朱丽华,黄丽丽,黄荷凤.米非司酮药物流产后子宫内膜雌激素和孕激素受体亚型观察[J].中华医学杂志,2003,(10):15-18. 朱丽华,黄丽丽,黄荷凤.米非司酮药物流产后子宫内膜雌激素和孕激素受体亚型观察[J].中华医学杂志,2003,(10):15-18.
6、 KAPP N,WHYTE P,TANG J,et al.A review of evidence for safe abortion care[J].Contraception,2013,88(3):350-363. KAPP N,WHYTE P,TANG J,et al.A review of evidence for safe abortion care[J].Contraception,2013,88(3):350-363.
7、 WORLD HEALTH ORGANIZATION.Clinical practice handbook for safe abortion[M].Geneva:WHO,2014. WORLD HEALTH ORGANIZATION.Clinical practice handbook for safe abortion[M].Geneva:WHO,2014.
8、 FIGO Working Group on Prevention of Unsafe Abortion and its Consequences,International Federation of Gynecology and Obstetrics.The combination of mifepristone and misoprostol for the termination of pregnancy[J].Int J Gynaecol Obstet,2011,115(1):1-4. FIGO Working Group on Prevention of Unsafe Abortion and its Consequences,International Federation of Gynecology and Obstetrics.The combination of mifepristone and misoprostol for the termination of pregnancy[J].Int J Gynaecol Obstet,2011,115(1):1-4.
9、 Safe Abortion:Technical and Policy Guidance for Health Systems.2nd ed.[C].Geneva:World Health Organization,2012. Safe Abortion:Technical and Policy Guidance for Health Systems.2nd ed.[C].Geneva:World Health Organization,2012.
10、 GAN K,ZHANG Y,JIANG X,et al.Perspectives of Chinese healthcare providers on medical abortion[J].Int J Gynaecol Obstet,2011,114(1):15-17. GAN K,ZHANG Y,JIANG X,et al.Perspectives of Chinese healthcare providers on medical abortion[J].Int J Gynaecol Obstet,2011,114(1):15-17.
11、 FIALA C,CAMERON S,BOMBAS T,et al.Outcome of first trimester medical termination of pregnancy:definitions and management[J].Eur J Contracept Reprod Health Care,2018,23(6):451-457. FIALA C,CAMERON S,BOMBAS T,et al.Outcome of first trimester medical termination of pregnancy:definitions and management[J].Eur J Contracept Reprod Health Care,2018,23(6):451-457.
12、 SELLMYER M A,DESSER T S,MATUREN K E,et al.Physiologic,histologic,and imaging features of retained products of conception[J].Radiographics,2013,33(3):781-796. SELLMYER M A,DESSER T S,MATUREN K E,et al.Physiologic,histologic,and imaging features of retained products of conception[J].Radiographics,2013,33(3):781-796.
13、 杨霄,罗丹.目测法与血红蛋白检测法评估产后出血的临床分析[J].中华妇幼临床医学杂志(电子版),2017,13(6):663-668. 杨霄,罗丹.目测法与血红蛋白检测法评估产后出血的临床分析[J].中华妇幼临床医学杂志(电子版),2017,13(6):663-668.
14、 COSTESCU D,GUILBERT E,BERNARDIN J,et al.Medical abortion[J].J Obstet Gynaecol Can,2016,38(4):366-389. COSTESCU D,GUILBERT E,BERNARDIN J,et al.Medical abortion[J].J Obstet Gynaecol Can,2016,38(4):366-389.
15、 WORKOWSKI K A,BOLAN G A;Centers for Disease Control and Prevention.Sexually transmitted diseases treatment guidelines,2015[J].MMWR Recomm Rep,2015,64(RR-03):1-137. WORKOWSKI K A,BOLAN G A;Centers for Disease Control and Prevention.Sexually transmitted diseases treatment guidelines,2015[J].MMWR Recomm Rep,2015,64(RR-03):1-137.
16、 USTUNYURT E,KAYMAK O,ISKENDER C,et al.Role of transvaginal sonography in the diagnosis of retained products of conception[J].Arch Gynecol Obstet,2008,277(2):151-154. USTUNYURT E,KAYMAK O,ISKENDER C,et al.Role of transvaginal sonography in the diagnosis of retained products of conception[J].Arch Gynecol Obstet,2008,277(2):151-154.
17、 CHEUNG K W,NGU S F,CHEUNG V Y.Sonographic characteristics of the uterus in asymptomatic women after second-trimester medical termination of pregnancy[J].J Ultrasound Med,2015,34(4):611-616. CHEUNG K W,NGU S F,CHEUNG V Y.Sonographic characteristics of the uterus in asymptomatic women after second-trimester medical termination of pregnancy[J].J Ultrasound Med,2015,34(4):611-616.
18、 中华医学会计划生育学分会.米非司酮配伍米索前列醇终止8~16周妊娠的应用指南[J] .中华妇产科杂志,2015,50(5):321-322. 中华医学会计划生育学分会.米非司酮配伍米索前列醇终止8~16周妊娠的应用指南[J] .中华妇产科杂志,2015,50(5):321-322.
19、 章兰英,巢永群.人工流产与药物流产对初次妊娠妇女再次妊娠分娩的影响[J].临床合理用药杂志,2017,10(33):152-153. 章兰英,巢永群.人工流产与药物流产对初次妊娠妇女再次妊娠分娩的影响[J].临床合理用药杂志,2017,10(33):152-153.
1、冯晓荣.妊娠物残留相关危险因素的分析及治疗方案的探讨[D].吉林大学,2025.DOI:10.27162/d.cnki.gjlin.2025.002001. 冯晓荣.妊娠物残留相关危险因素的分析及治疗方案的探讨[D].吉林大学,2025.DOI:10.27162/d.cnki.gjlin.2025.002001.
上一篇
下一篇
出版者信息








《广州医药》公众号
目录